CPT 17106: Laser Destruction of Cutaneous Vascular Lesion <10 cm²
CPT code 17106 covers laser or other nonincisional destruction of a cutaneous vascular proliferative lesion that is less than 10 cm² in area. This code is used to report a bloodless, nonexcisional procedure commonly performed in outpatient dermatology or ambulatory surgical settings. Nationally, it matters because vascular lesion treatments are common in cosmetic and medical dermatology, and clear coding supports appropriate tracking, reimbursement, and clinical communication.
Key payers in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical service represented by the code, typical sites of service, and the procedural context for which the code is appropriate. The publication also provides benchmarks and policy-relevant details related to coverage and billing practices for nonexcisional laser destruction of vascular lesions, as well as coding nuances and related service-level considerations.
This summary is intended for national audiences including coding professionals, dermatology clinicians, and payer policy analysts seeking a clear, practical reference to CPT code 17106 and its clinical application.
Customize your policy alerts
Sign up for cpt 17106 policy alerts
Get alerted when payer policies referencing 17106 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 17106 describes destruction of a cutaneous vascular proliferative lesion measuring less than 10 cm². The procedure is typically performed using laser technologies such as argon, pulsed-dye, or YAG devices and is characterized as a bloodless surgical technique because no skin incision is made.
Service Type: Laser destruction of cutaneous vascular lesion
Typical Site of Service: Outpatient dermatology clinic or ambulatory surgical center, where laser therapies for vascular skin lesions are commonly performed.